e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An audio-imaging approach to measure the degree of severity of patients suffering from DPLD disease
A. Mondal (Mangalore, India), P. Banerjee (Mangalore, India)
Source:
International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session:
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session type:
Thematic Poster
Number:
2988
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mondal (Mangalore, India), P. Banerjee (Mangalore, India). An audio-imaging approach to measure the degree of severity of patients suffering from DPLD disease. 2988
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Is pain a risk factor for symptom severity in patients with chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020
The comparisons of severity scoring systems for community acquired pneumonia patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
A new paradigm for classification of disease severity and progression of COPD
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Cough rate may predict disease severity in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Distribution of severity of patients with obstructive lung disease in an at risk population
Source: Eur Respir J 2004; 24: Suppl. 48, 474s
Year: 2004
Relationship between pharmacotherapy and severity of disease in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007
Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Is there any relationship between the duration to diagnosis of COPD and severity of the disease?
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Factors associated with disease severity in young adult patients suffering from OSA
Source: Annual Congress 2010 - Screening for sleep-disordered breathing
Year: 2010
The cardiovascular comorbidity and the risk of stroke by means of CHADS2- VASc scale in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001
The types and frequency of mental disorders in COPD patients (pts) according to severity of COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Gerd questionnaire as a tool for diagnosing GERD in patients with chronic obstructive pulmonary disease.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Symptom variability in patients with severe COPD: a pan-European cross-sectional study
Source: Eur Respir J 2011; 37: 264
Year: 2011
The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2015; 46: 988-1000
Year: 2015
The relationship between depression, medication and stage of the disease in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Walking strategy in severe chronic lung disease (CLD) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 309s
Year: 2005
Association of caregiver burden and depression in caregivers of patients with chronic respiratory failure secondary to advanced and end stage lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept